NLGN3 and melanoma: RNA-seq and ATAC-seq analyses demonstrate that melanoma cells reactivate enhancer sets that control axon guidance (SLIT2, ROBO1, SEMA3A), neurotransmission (GRIN2A, SYT1, SLC17A7), and synaptic structure (DLG4, NRXN1, NLGN3) [37,38].